[Use of tadalafil in the rehabilitation of patients with a history of posterior urethral injury in the context of pelvic fracture]

Rev Int Androl. 2018 Jan-Mar;16(1):15-19. doi: 10.1016/j.androl.2017.02.004. Epub 2017 May 15.
[Article in Spanish]

Abstract

Objective: To evaluate the tadalafil effect in the treatment of erectile dysfunction as a consequence of posterior urethral injury.

Material and methods: This is a retrospective study that included patients with posterior urethral injury caused by previous pelvic fracture; our patients received emergency urethral alignment and urethroplasty between 8 to 10weeks after trauma. To assess the degree of erectile dysfunction pre- and post-treatment, we applied the questionnaire of International Index of Erectile Function (IIEF-5). Statistics Wilcoxon test and descriptive statistics were performed.

Results: Eight patients were included in this study, with an average age of 32.5years; the IIEF scale prior to treatment was on average 8.5 points and increased to 12.36 points with a value of P=.011.

Discussion: These eight patients showed erectile dysfunction at the time of IIEF assessment, this due to emergency urethral realignment arising from the trauma caused by pelvic fracture. Treatment with inhibitors of 5-phosphodiesterase (iPDE5) is the first-line treatment in patients with erectile dysfunction because it is efficient, non-invasive and well tolerated. In this study we found results indicating good response to this treatment in 7 out of the 8 patients (87.5%). Only one patient showed no improvement after treatment, due to the presence of risk factors such as age (65years), tobacco use, and high blood pressure.

Conclusion: The 87.5% of patients with urethral injury medicated with tadalafil were rehabilitated.

Keywords: Disfunción eréctil; Erectile dysfunction; Lesión uretral; Tadalafil; Tadalafilo; Urethral injury.

MeSH terms

  • Adult
  • Erectile Dysfunction / drug therapy*
  • Erectile Dysfunction / etiology
  • Fractures, Bone / complications*
  • Humans
  • Male
  • Middle Aged
  • Pelvic Bones / injuries
  • Phosphodiesterase 5 Inhibitors / adverse effects
  • Phosphodiesterase 5 Inhibitors / therapeutic use*
  • Retrospective Studies
  • Risk Factors
  • Surveys and Questionnaires
  • Tadalafil / adverse effects
  • Tadalafil / therapeutic use*
  • Treatment Outcome
  • Urethra / injuries*

Substances

  • Phosphodiesterase 5 Inhibitors
  • Tadalafil